Appointments support Company pipeline with major programs and readouts expected in coming years.
The firm is working on a treatment for diabetic macular edema. LAUSANNE, SWITZERLAND — Oculis, a biotechnology company focused on eye drops, has closed a $20.3...
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.
Advertisement